Novel pentamidine analogs in the treatment of experimental Pneumocystis carinii pneumonia
about
sameAs
Crystal structure of gamma-oxapentamidine complexed with d(CGCGAATTCGCG)2. The effects of drug structural change on DNA minor-groove recognitionTreatment of experimental pneumocystosis: review of 7 years of experience and development of a new system for classifying antimicrobial drugsStructure-activity relationships of analogs of pentamidine against Plasmodium falciparum and Leishmania mexicana amazonensisInhibition of Cryptosporidium parvum in neonatal Hsd:(ICR)BR Swiss miceby polyether ionophores and aromatic amidinesSelective inhibition of topoisomerases from Pneumocystis carinii compared with that of topoisomerases from mammalian cellsGuanylhydrazones in therapy of Pneumocystis carinii pneumonia in immunosuppressed rats.Structure-in vitro activity relationships of pentamidine analogues and dication-substituted bis-benzimidazoles as new antifungal agentsIn vitro antifungal activities of a series of dication-substituted carbazoles, furans, and benzimidazolesComparative efficacy evaluation of dicationic carbazole compounds, nitazoxanide, and paromomycin against Cryptosporidium parvum infections in a neonatal mouse model.In-vitro activity of dicationic aromatic compounds and fluconazole against Cryptococcus neoformans and Candida sppActivity of cationically substituted bis-benzimidazoles against experimental Pneumocystis carinii pneumoniaAnti-Pneumocystis activities of aromatic diamidoxime prodrugs.Structure-activity relationships of pentamidine analogs against Giardia lamblia and correlation of antigiardial activity with DNA-binding affinity.Antifungal agents: chemotherapeutic targets and immunologic strategies.In vitro selection and in vivo efficacy of piperazine- and alkanediamide-linked bisbenzamidines against Pneumocystis pneumonia in mice.Aromatic diamidines as antiparasitic agents.Activity of pentamidine and pentamidine analogs against Toxoplasma gondii in cell cultures.Comparison of corticosteroid- and L3T4+ antibody-immunosuppressed mouse models of Pneumocystis carinii pneumonia for evaluation of drugs and leukocytes.Improved rat model of Pneumocystis carinii pneumonia: induced laboratory infections in Pneumocystis-free animals.Diamidines versus Monoamidines as Anti-Pneumocystis Agents: An in Vivo Study.Anti-Pneumocystis carinii pneumonia activity of dicationic 2,4-diarylpyrimidines.Structure-activity relationships of pentamidine-affected ion channel trafficking and dofetilide mediated rescue.New prodrugs of the antiprotozoal drug pentamidine.Microculture screening assay for primary in vitro evaluation of drugs against Pneumocystis carinii.Sequence-selective binding to DNA of bis(amidinophenoxy)alkanes related to propamidine and pentamidine.Identification and characterization of an endo/exonuclease in Pneumocystis carinii that is inhibited by dicationic diarylfurans with efficacy against Pneumocystis pneumonia.Efficient and specific cardiac IK₁ inhibition by a new pentamidine analogue.
P2860
Q27730315-40EF2DFC-8B8A-47C2-BAA9-B0AE54B047BDQ28316964-DE0A812A-245A-4139-BBF0-61491B6FE179Q28331178-107E33DB-0DCE-4AC6-B91A-452B41BA675FQ28333686-CEC6C52D-1E6E-4669-95BE-4A66C5BC341BQ28368229-F062B116-56DD-41F5-AAAE-2F0D8809E406Q28368745-F5F3D6E2-BDD9-4A5B-B061-DED6832853BEQ28369009-D490BB5C-BA39-40EB-897B-6DEAEA20C00CQ28369015-D57FE9FF-7525-4190-81B8-0A3DD33191BCQ28369145-46A7DB58-A828-4240-A2E7-45906F578DEEQ28372154-7687C314-8EFC-4097-940C-050C01C02B2BQ28378308-01BCB015-85AF-449D-8A3E-9AC9EBA70FD0Q28379412-86ACFCA4-E346-4627-B61C-F1771806ADC0Q33743795-772515E5-3AEB-4038-B67E-8CB3C3BE861BQ34400044-6601F91D-082F-45CE-AD16-35E6D463FB8CQ34721573-A7095666-0BC9-4DE0-BA58-AED68AA1E6BBQ36210897-85ED8F95-E213-44E9-84EF-BF62027ED508Q36754982-BA6FA204-6003-4A70-8F09-1CC80409F305Q36930833-81488712-A836-46E8-8A66-3A35B56FEF8BQ36943574-E124838D-A2F4-47DB-AAAF-1D55D3D14240Q37277420-B53B5FE7-AF20-482F-BFA8-297C5D92AD4CQ38891104-A16045F2-68F5-491B-963A-70731C28E8BAQ39435268-9B09B3A0-30AC-42CD-89D3-C6E68BABEFDAQ39460980-B2956A4F-A4B2-4645-8548-DFEA1DBDBA65Q40087568-653E388C-16C8-4B8A-9BDA-88CCCDDDCCD9Q41937274-6ECD0977-E48D-4868-A702-45EB6EB5394CQ42544635-1A08FC42-616A-4CEA-8970-721B56248415Q51034289-5C4B79D3-A1BE-46A9-A9AA-3EFF541D9095
P2860
Novel pentamidine analogs in the treatment of experimental Pneumocystis carinii pneumonia
description
1990 nî lūn-bûn
@nan
1990 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Novel pentamidine analogs in the treatment of experimental Pneumocystis carinii pneumonia
@ast
Novel pentamidine analogs in the treatment of experimental Pneumocystis carinii pneumonia
@en
Novel pentamidine analogs in the treatment of experimental Pneumocystis carinii pneumonia
@nl
type
label
Novel pentamidine analogs in the treatment of experimental Pneumocystis carinii pneumonia
@ast
Novel pentamidine analogs in the treatment of experimental Pneumocystis carinii pneumonia
@en
Novel pentamidine analogs in the treatment of experimental Pneumocystis carinii pneumonia
@nl
prefLabel
Novel pentamidine analogs in the treatment of experimental Pneumocystis carinii pneumonia
@ast
Novel pentamidine analogs in the treatment of experimental Pneumocystis carinii pneumonia
@en
Novel pentamidine analogs in the treatment of experimental Pneumocystis carinii pneumonia
@nl
P2093
P2860
P356
P1476
Novel pentamidine analogs in the treatment of experimental Pneumocystis carinii pneumonia
@en
P2093
J D Geratz
K A Ohemeng
R R Tidwell
S D Morrison
P2860
P304
P356
10.1128/AAC.34.6.1026
P407
P577
1990-06-01T00:00:00Z